United States
3 weeks ago

Job Overview

Pay
Not disclosed

Job description

Location:
United States
Work arrangement:
On-site

Role Summary

The Director of Strategic Pricing & Contracting Analytics is responsible for developing and leading the analytic, financial, and operational capabilities that support pricing and contracting decision-making across the organization. This role serves as the primary business lead for deal modeling, contracting analytics, data governance initiatives, reporting, GTN / ASP forecasting support, and process innovation. The position partners closely with Strategic Pricing & Contracting leadership, Finance, Market Access, Commercial Operations, and Advanced Analytics to deliver actionable insights and scalable capabilities that improve decision quality and execution.

Responsibilities

  • Leads all financial evaluation and deal modeling for pricing and contracting proposals to support business decision-making and account strategy development presented through the pricing and contracting governance review processes.
  • Inform GTN / ASP forecasting, budget, contracting strategy, and contract performance assessments
  • Partner closely with Finance, Accounting, Account teams, Government Pricing, Legal and Advanced Analytics to ensure alignment of data, model assumptions, and reporting
  • Serve as Strategic Pricing & Contracting lead for Market Access and enterprise data initiatives
  • Develop and maintain dashboards, scorecards, and reporting tools that provide visibility into contracting performance, customer trends, and business outcomes
  • Identify, evaluate, and implement new technologies, AI solutions, automation capabilities, and process improvements
  • Establish and maintain data standards, reporting methodologies, and analytical best practices for contracting analysis
  • Generate actionable business insights that support pricing, contracting, reimbursement, and access decisions
  • Enhance organizational capabilities related to contracting operations, modeling, reporting, and business intelligence

Requirements

  • 10+ years of experience in pharmaceutical, biotechnology, healthcare consulting, market access, commercial operations, finance, or related analytical functions.
  • Demonstrated experience supporting strategic pricing, contracting, market access, reimbursement, or gross-to-net decision-making.
  • Deep understanding of U.S. payer, provider, specialty pharmacy, distribution and alternate site of care channels, including the financial and operational drivers that influence access and contracting strategies.
  • Strong knowledge of U.S. healthcare reimbursement, payer dynamics, and market access strategies.
  • Demonstrated expertise in gross-to-net, ASP, contract performance, and pricing analytics.
  • Proven ability to lead teams and influence decisions through data-driven insights.
  • Experience supporting executive governance and strategic decision-making processes.
  • Track record of developing innovative analytical capabilities, dashboards, automation solutions, and business intelligence tools.
  • Exceptional financial modeling, problem-solving, and communication skills.
  • Experience in rare disease and medical benefit buy & bill portfolios
  • Experience with Rare Disease portfolios preferred

#LI-ST1 #LI-Remote

About Alnylam

We are the leader in RNAi therapeutics – a revolutionary approach with the potential to transform the lives of people with rare and common diseases. Built on Nobel Prize-winning science, Alnylam has delivered the breakthroughs that made RNAi therapeutics possible and are just at the beginning of what’s possible. Our deep pipeline, late-stage programs, and bold vision reflect our core values: fierce innovation, passion for excellence, purposeful urgency, open culture and commitment to people. We're proud to be a globally recognized top employer, where an authentic, inclusive culture and breakthrough thinking fuel one another.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. Qualified applicants will receive consideration for employment without regard to their sex, gender or gender identity, sexual orientation, race, color, ethnicity, national origin, ancestry, citizenship, religion, creed, physical or mental disability, pregnancy status or related conditions, genetic information, veteran or military status, marital or familial status, political affiliation, age, or any other factor protected by federal, state, or local law. Alnylam is an E-Verify Employer.

Before applying, please review Alnylam's ⁠Candidate Privacy Notice regarding how Alnylam handles Personal Data you provide with your application for employment.

The pay range below reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on a number of factors including, but not limited to, relevant experience, skills, and education. This role is eligible for an annual short-term incentive award (e.g., bonus or sales incentive) and an annual long-term incentive award (e.g., equity).

Alnylam’s robust Total Rewards package is designed to support your overall health and well-being. We offer comprehensive benefits including medical, dental, and vision coverage, life and disability insurance, a lifestyle reimbursement program, flexible spending and health savings accounts and a 401(k)with a generous company match. Eligible employees enjoy paid time off, wellness days, holidays, and two company-wide recharge breaks. We also offer generous family resources and leave. Our commitment to your well-being reflects our belief that caring for our people fuels the impact we create together.

  • Learn more about these and additional benefits offered by Alnylam by visiting the Benefits section of the Careers website: https://www.alnylam.com/careers
  • U.S. Pay Range
Role:
Director, Strategic Pricing and Contracting Analytics

Company profile

Alnylam Pharmaceuticals

alnylam.com

Alnylam Pharmaceuticals is an independent biopharmaceutical company that develops RNA interference (RNAi) therapeutics, a class of medicines that treats diseases by silencing the genes that cause or contribute to them. Founded in 2002 in Cambridge, Massachusetts, by researchers including Phillip Sharp and Phillip Zamore, Alnylam saw the world's first RNAi therapeutic approved in 2018, and five more of its medicines have been approved since. The company is developing therapies for both rare and prevalent diseases and is listed on the Nasdaq.

Company Size
1,000 - 5,000 employees
Headquarters
Cambridge, Massachusetts, United States
Founded
2002
Founders
Phillip Sharp, David Bartel, Thomas Tuschl, Paul Schimmel, Phillip Zamore
Funding Stage
Public

More jobs at Alnylam Pharmaceuticals

Similar Commercial - US TTR jobs at other companies